Search
-
Searchresult: Team
Coordinating Investigator (Leiter der klinischen Prüfung*) *According to § 40 German Drug Law (AMG) KiTZ Clinical Trial Unit Coordinating Molecular…
-
Searchresult: INFORM registry
Search for targets The principle of the INFORM registry is to analyze tumor material obtained from routine biopsies as precisely as possible using state-of-the-art molecular genetic methods,…
-
Searchresult: Contact us
KiTZ Clinical Trial Unit Cecilia Zuliani, PhD / Ruth Witt, M.Sc. MA Im Neuenheimer Feld 130/3 69120 Heidelberg Tel: 06221-56-6913 / 06221-56-7294 Fax: 06221-56-5974 INFORM_info@DKFZ.de Data…
-
Searchresult: Mechanisms of Genome Control
Our Research The Feldmann lab studies how genes are regulated in time and space, and how these programs become corrupted in cancers. One of the most fascinating processes in biology is the…
-
Searchresult: Publications
All publications since 2020 Alle theses since 2017 All publications until end of 2019
-
Searchresult: 20240318_INFORM_Webseite-PatVertreter_Deutsch_CZ.pdf
Ehrenamtliche Patientenvertreter Die Patientenvertreter arbeiten ehrenamtlich und bieten ihre Unterstützung Eltern mit betroffenen Kindern an. Sie tun dies in ihrer Freizeit, freiwillig und ohne…
Document -
Searchresult: 20161014_Registration_Shipment_Manual_for_Germany_version_10.pdf20161014_Registration_Shipment_Manual_for_Germany_version_10.pdf PDF, 686.25 KB Document content type: Document
Registration & Shipment Manual INFORM INdividualized Therapy FOr Relapsed Malignancies in Childhood Coordinating Investigator Registry: Prof. Dr. med. Olaf Witt NCT Clinical Trial Center Heidelberg…
Document -
Searchresult: Registration_Shipment_Manual_for_international_patients_v1_20161202.pdfRegistration_Shipment_Manual_for_international_patients_v1_20161202.pdf PDF, 592.96 KB Document content type: Document
Registration & Shipment Manual International Patients INFORM INdividualized Therapy FOr Relapsed Malignancies in Childhood Coordinating Investigator Registry: Prof. Dr. med. Olaf Witt NCT Clinical…
Document -
Searchresult: Viable_Tissue_Shipment_for_Drug_Screen_INFORM_short_instruction_v6.pdfViable_Tissue_Shipment_for_Drug_Screen_INFORM_short_instruction_v6.pdf PDF, 186.14 KB Document content type: Document
version 6 INFORM – Drug Sensitivity Profiling We are offering optional Drug Sensitivity Profiling in our INFORM platform (INFORM amendment 5) on short term cultures from viable tumor tissue. For…
Document -
Searchresult: Liquid_Biopsies_INFORM_shortinstruction_V1.0.pdf
INFORM – Liquid Biopsies The submission of liquid biopsy samples is requested for all INFORM patients with solid and brain tumors but is not mandatory for INFORM inclusion. V1.0 October 2024 …
Document